Deregulation of SPOP in Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Speckle-type POZ protein (SPOP) functions as a key adaptor in the CULLIN3/RING-box1 E3 ubiquitin ligase complex.
• SPOP is implicated in various cancers, with mutations in prostate and endometrial cancers, and overexpression in renal cell carcinoma (RCC).

Purpose of the Study:

• To review recent advancements in understanding SPOP's upstream regulators and downstream targets.
• To highlight the role of SPOP mutations and overexpression in cancer development.
• To discuss the therapeutic potential of targeting SPOP in cancer treatment.

Main Methods:

• Literature review of studies on SPOP function, regulation, and involvement in cancer.
• Analysis of SPOP's interactions with substrates and their impact on cellular pathways.
• Examination of SPOP's dual role as a tumor suppressor and oncoprotein in different cancer types.

Main Results:

• SPOP mediates polyubiquitination of diverse substrates, influencing androgen receptor signaling, DNA repair, metabolism, and immunity.
• Cancer-associated SPOP mutants often disrupt substrate binding and ubiquitination, affecting critical cancer-related pathways.
• SPOP exhibits context-dependent roles, acting as a tumor suppressor in some cancers and an oncoprotein in RCC.

Conclusions:

• SPOP's complex roles in cancer pathogenesis are influenced by its mutations and expression levels.
• Understanding SPOP's regulatory network and substrate interactions is crucial for deciphering its oncogenic or tumor-suppressive functions.
• Targeting SPOP presents a promising avenue for novel cancer therapies, particularly in RCC.